Member Info for WeTookPelham

...you were just saying Ripley I didn't back it up? Now what?

....1000 shares timed at 10:10:28

I paid 20.40.

As mentioned by others when it was closer to 25p... "Cheap as chips". Well I got even more chips for my money today!
As per usual a scheduled RNS has put a dampner on the SP but for me personally nothing has changed, and the modi trial updates could be explosive. All IMO.

Even (very) long term holders like myself still never seem to learn that preplanned RNS's are nearly always bad for the SP. Whilst I tried hard not to get too carried away, I, like others still had hopes that the interims contained some extra juicy news. But alas, no. Hope springs enternal I guess?

But as mentioned. the key thing is interims are out of the way now. Onwards and upwards you'd think now?? Purely IMO I feel the next RNS will be some kind of deal news.

Looking over at the other forum, there seems to be no evidence of this roadshow at all, so it's all somewhat bizzare IMO.

There is a link mentioning the Stifel price upgrade (posted on here already I beleive), but where the actual source of the price upgrade came from I'm still not clear.

"...an outstanding offer for the whole company. Best scenario ...an opening offer from Merck followed by a bidding war : )) "

I'm with you on this, I hope someone comes in for the whole lot, not interested in long term licensing etc.

"...The biggie is deals for Modi/immunobody or the whole shebang. I find it hard to believe big pharma aren't watching and waiting on sidelines for the right data."

Let's not forget Merck have stated categorically they are actively looking for smaller bio's.

Btw are there any links regarding the Stifel roadshow? It appears to be hearsay atm.

Violndog, Scancell already have deals with the mabs products and more are expected (we think), with the expected upfront payments/ongoing payments. Don't forget the Genmab deal and it's payments.

The biggie is deals for Modi/immunobody or the whole shebang. I find it hard to believe big pharma aren't watching and waiting on sidelines for the right data.

But either way I don't think funds will need to be raised as other sources of income "should" materialise and already do to an extent. All IMO.

"Zakari Therapeutics Limited

The Board felt that there was no further need to retain the Zakari Therapeutics subsidiary company. Therefore, application has been made to the Registrar of Companies for Zakari Therapeutics Limited, a non-trading subsidiary of Scancell Limited, to be dissolved."

I'll be honest didn't realise it was mentioned in yesterday's interims. Not sure if it was ever mentioned in any other RNS's? The thing is they clearly thought it was worth setting up initially. Something clearly must have changed with their plans to decide to dissolve it?

The "diagnosis" thread I referred to before is actively being updated. Some interesting posts including link to this:
https://www.ansonmackay.com/blog
https://www.ansonmackay.com/post/hello-2023-you-re-an-unexpected-but-welcome-delight

Progress on companies house RE getting it struck off?

31 Jan 2023 First Gazette notice for voluntary strike-off
This document is being processed and will be available in 10 days.

This roadshow seems to be a new thing? Why now, why with Stifel? Can someone remind me of the relationship please.

Also the price target upgrade from Stifel, has anyone seen a relevant webpage. I may be wrong but i don't recall them giving Scancell price targets before?

Yes excellent and informative post EmptyEnd.

But RE "I see the roadshow as significant in that reprofiling - putting groundbait out into the market to alert investors to near-term newsflow."

What is this Stifel(?) roadshow I keep reading about?

A few more recent mentions, encouraging cancer patients to seek out the Modi trial.
Do a search for 'modi' in the search bar.
Reading posts on there makes me wonder why consultants seem so out of the loop regarding trials?

RE dark/daftprince and the like, your research RW shows they only come out to play on days when they can have a dig at the SP.
Oh it's not suspicious at all is it?

Could we be getting more "unscheduled" news this week I wonder?

"Some wish to get high price to short your shares".

I think you'll find on here it's mostly the other way round, de-rampers trying to get cheaper shares. The ramping you seem to infer is happening on here is usually light-hearted, but is usually backed up with reasons/fact for price targets. The de-rampers just post random unjustified posts with no backing.

Also, as I mentioned, on my platform at least I am not able to short Scancell. And according to another member it seems restricted on AIM. So where are you getting your viewpoint from RE shorting?

But even the dumbest traders/boiler room de-rampers have some idea of the potential here, so why would they not want cheaper shares.

...is the next unplanned RNS. What potential news will it be? And how soon? Tomorrow is fine by me.

Is it Chester18 who posts those excellent summary points?

...and 65k @22.40. Bargain hunters aplenty it seems.